These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16182312)

  • 21. Flexion contracture after total knee arthroplasty in a patient with Parkinson's disease: successful treatment with botulinum toxin type A.
    Shah SN; Hornyak J; Urquhart AG
    J Arthroplasty; 2005 Dec; 20(8):1078-80. PubMed ID: 16376267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
    Dhawan V; Dhoat S; Williams AJ; Dimarco A; Pal S; Forbes A; Tobías A; Martinez-Martin P; Chaudhuri KR
    J Neurol Sci; 2006 Oct; 248(1-2):158-62. PubMed ID: 16780888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paroxysmal exercise-induced dystonia as a presenting feature of young-onset Parkinson's disease.
    Bozi M; Bhatia KP
    Mov Disord; 2003 Dec; 18(12):1545-7. PubMed ID: 14673897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms.
    Doan JB; Melvin KG; Whishaw IQ; Suchowersky O
    Behav Brain Res; 2008 Dec; 194(2):207-13. PubMed ID: 18692094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of dystonia in Parkinson's disease.
    Tsui JK
    Adv Neurol; 2003; 91():361-4. PubMed ID: 12442694
    [No Abstract]   [Full Text] [Related]  

  • 27. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
    Sheffield JK; Jankovic J
    Expert Rev Neurother; 2007 Jun; 7(6):637-47. PubMed ID: 17563247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Micro lesion effect of the globus pallidus internus and outcome with deep brain stimulation in patients with Parkinson disease and dystonia.
    Cersosimo MG; Raina GB; Benarroch EE; Piedimonte F; Alemán GG; Micheli FE
    Mov Disord; 2009 Jul; 24(10):1488-93. PubMed ID: 19475579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoring balance in focal limb dystonia with botulinum toxin.
    Sheean G
    Disabil Rehabil; 2007 Dec; 29(23):1778-88. PubMed ID: 18033603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metatarsal fracture as a consequence of foot dystonia in Parkinson's disease.
    McDade E; Weiner WJ; Shulman LM
    Parkinsonism Relat Disord; 2008; 14(4):353-5. PubMed ID: 18457984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I
    Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].
    Buchwald B; Angersbach D; Jost WH
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena.
    Bloem BR; Hausdorff JM; Visser JE; Giladi N
    Mov Disord; 2004 Aug; 19(8):871-84. PubMed ID: 15300651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical management of advanced Parkinson's disease.
    Goudreau JL
    Clin Geriatr Med; 2006 Nov; 22(4):753-72, v. PubMed ID: 17000334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dystonic posture of lower extremities associated with myelomeningocele: successful treatment with botulinum A toxin in a six-month-old child.
    Heinen F; Korinthenberg R; Stücker R; Deuschl G
    Neuropediatrics; 1995 Aug; 26(4):214-6. PubMed ID: 8544962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease.
    Schneider SA; Edwards MJ; Cordivari C; Macleod WN; Bhatia KP
    Mov Disord; 2006 Oct; 21(10):1722-4. PubMed ID: 16817198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?
    Nóbrega AC; Rodrigues B; Torres AC; Enzo A; Melo A
    J Neurol Sci; 2007 Feb; 253(1-2):85-7. PubMed ID: 17229441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptom and gait changes after sensory attention focused exercise vs aerobic training in Parkinson's disease.
    Sage MD; Almeida QJ
    Mov Disord; 2009 Jun; 24(8):1132-8. PubMed ID: 19373930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Runner's dystonia.
    Wu LJ; Jankovic J
    J Neurol Sci; 2006 Dec; 251(1-2):73-6. PubMed ID: 17097111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.